Displaying 1 - 10 items out of 10 results
ILCN article
Regulating Artificial Intelligence
… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN: Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh: FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …
ILCN article
Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says
… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …
ILCN article
Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams
… Opportunities for Innovative Multidisciplinary Cancer Research Teams …
ILCN article
NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy
… NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for …
ILCN article
US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective
… of care and limited resources to review applications, researchers say they support the agency’s decision not to …
ILCN article
Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds
… Researchers evaluating the clinical significance of …
ILCN article
Pragmatic Approach to Trial Design Born from Lung-MAP Substudy
… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …
ILCN article
Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates
… Researchers say increased screening of at-risk populations, …
ILCN article
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …
ILCN article
Recurrence Remains a Risk Even for Patients Diagnosed via Screening
… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …









